Longo Sherri A, Dola Chi P, Pridjian Gabriella
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
South Med J. 2003 Sep;96(9):891-9. doi: 10.1097/01.SMJ.0000084385.85123.08.
Hypertensive disorders during pregnancy, which account for approximately 15% of pregnancy-related deaths, represent the second-leading cause of morbidity and mortality in the United States. New classifications recommended by the National Institutes of Health's Working Group on High Blood Pressure in Pregnancy have decreased the confusion often associated with these disorders. The cause of preeclampsia-eclampsia still remains elusive, but continued research has provided hope with regard to screening, improved diagnosis, and management. Risk factors that have recently gained attention include inherited thrombophilias, inherited metabolic disorders, and lipid disorders. Treatment and management of the hypertensive disorders of pregnancy have not changed substantially in the past 50 years. Prevention of preeclampsia-eclampsia has been unsuccessful, and recurrence risks remain high. Careful diagnosis, classification, and further investigation of the causes of hypertensive disorders in pregnancy are needed to achieve optimal management of affected women and their fetuses.
妊娠期高血压疾病约占与妊娠相关死亡的15%,是美国发病和死亡的第二大原因。美国国立卫生研究院妊娠高血压工作组推荐的新分类减少了通常与这些疾病相关的混淆。子痫前期-子痫的病因仍然不明,但持续的研究为筛查、改善诊断和管理带来了希望。最近受到关注的危险因素包括遗传性血栓形成倾向、遗传性代谢紊乱和脂质紊乱。在过去50年中,妊娠期高血压疾病的治疗和管理没有实质性变化。子痫前期-子痫的预防一直未成功,复发风险仍然很高。需要对妊娠期高血压疾病的病因进行仔细诊断、分类和进一步调查,以实现对受影响妇女及其胎儿的最佳管理。